Brett Matthew Hall, CHIEF SCIENTIFIC OFFICER at Immuneering Corp (IMRX), bought 6,035 shares at $4.15 ($25K) on 2026-06-15, disclosed to the SEC on 2026-06-16.
Open-market purchase of $25k IMRX by CHIEF SCIENTIFIC OFFICER. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| IMRX | BUY | 2024-03-21 | $20K | — | Filing → |
| IMRX | BUY | 2022-05-27 | $10K | — | Filing → |
| IMRX | BUY | 2022-03-23 | $8K | — | Filing → |